Commission steps back on total bovine spongiform encephalopathy (BSE) ban
This article was originally published in Clinica
Executive Summary
The medical devices and diagnostics industries appear to be winning further concessions in their battle for exemption from the forthcoming EU ban on the use of certain animal-derived materials in medical products.